Ingrid Wertz

Chief Executive Officer Lyterian Therapeutics

Seminars

Wednesday 28th January 2026
Co-Opting the Ubiquitin System for Therapeutic Benefit
12:00 pm
  • Reviewing rational drug design strategies for molecular glues
  • Comparing and contrasting different molecular glue systems
  • Investigating more streamlined and complementary strategies to evaluate optimized compounds
Ingrid